Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


UCL welcomes first Technology Entrepreneurship Fulbright Scholar

25 October 2013

Julie Markham

UCL has welcomed its first Fulbright Scholar for the university’s Masters programme in Technology Entrepreneurship.

Julie Markham – who is 27 and comes from the US – was selected out of hundreds of other applicants to benefit from the first scholarship, announced earlier this year. She will see the Fulbright Programme fully fund her through the Masters programme and provide a stipend for living expenses.

Read: UCL News